- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cells ; 9 (2020), 9. - Art.-Nr. 2103. - eISSN 2073-4409
- Keyword
-
Plattenepithelcarcinom
Squamöser Krebs
Antigen
T-Lymphozyt
Impfung
Antikörper
Immuntherapie
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2020
- Creator
-
von Witzleben, Adrian
Wang, Chuan
Laban, Simon
Savelyeva, Natalia
Ottensmeier, Christian H.
- DOI
-
10.18725/OPARU-43178
- URN
-
urn:nbn:de:bsz:289-oparu-43254-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- von Witzleben, Adrian
- Wang, Chuan
- Laban, Simon
- Savelyeva, Natalia
- Ottensmeier, Christian H.
- Universität Ulm
Time of origin
- 2020
Other Objects (12)
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy